Scalpel Weekly News

Week of: December 09, 2013

IN THE NEWS


Rising Rates of Whooping Cough; Infection Spread After Vaccination

A new study is helping to provide a better understanding of vaccines for whooping cough, the common name for the disease pertussis. Based on an animal model, the study conducted by the FDA and published in The Proceedings of the National Academy of Sciences shows that that although individuals immunized with an acellular pertussis vaccine may be protected from the disease, they may still become infected with the bacteria without always getting sick. Click title to continue reading... 


 
MEDICAL ALERTS


Meningitis Outbreaks at Princeton and UC Santa Barbara

The CDC is monitoring two recent outbreaks of meningococcal disease at Princeton University and the University of California, Santa Barbara. In anticipation of the holiday travel season, the CDC issued an outbreak status update and advice to reduce the risk of spreading the disease. Click title to continue reading... 



Glucose Test Strips Recalled Due to Low Readings

Abbott recalled twenty lots of FreeStyle and FreeStyle Lite Blood Glucose Test Strips in the United States. These lots of test strips may produce erroneously low blood glucose results when used with the OmniPod Insulin Management System. Additionally, the the test strips may produce erroneously low blood glucose results when used with the "FreeStyle Blood Glucose Meter" and "FreeStyle Flash Blood Glucose Meter,” neither of which have been in production since 2010. Click title to continue reading... 



Risk of Heart Attack and Death with Cardiac Nuclear Stress Test Drugs

The FDA warned health care professionals of the rare but serious risk of heart attack and death with use of the cardiac nuclear stress test drug agents Lexiscan (regadenoson) and Adenoscan (adenosine). The FDA approved changes to the drug labels to reflect these serious events and updated their recommendations for use of these agents. Click title to continue reading... 


  CASE ALERTS


Product Liability Claims Fail Against Blood Thinner Manufacturers

Plavix is used to treat individuals at risk for heart attack, stroke, and circulation problems. Because Plavix inhibits the formation of blood clots, it increases the risk of bleeding. The Plavix label disclosed this risk. The FDA approved the use of Plavix with aspirin to treat individuals suffering from acute coronary syndrome (“ACS”). Click title to continue reading...   



ER Medical Director Not Liable for Staff’s Failure to Implement Chest Pain Protocol

A woman suffered cardiac arrest and died in the emergency room. The woman’s daughter, individually and as administrator of the mother’s estate, sued the medical director of the emergency department, alleging that her mother could have been saved, if only her treating physician and nurse had promptly and properly implemented a chest pain protocol that the hospital had adopted. Click title to continue reading... 



Radiation Oncology Provider Pays Millions for False Medicare Claims

Vantage Oncology LLC (Vantage) has agreed to pay the government more than $2.08 million to settle allegations that it submitted false claims to Medicare for radiation oncology services performed at its Illinois centers from 2007 through June 2012. Click title to continue reading...